CN Stock MarketDetailed Quotes

000627 Hubei Biocause Pharmaceutical

Watchlist
  • 2.21
  • -0.02-0.90%
Trading May 29 14:58 CST
10.92BMarket Cap-13899P/E (TTM)

Hubei Biocause Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hubei Biocause Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 30, 2024

Revenue(YoY)

17.49B

-20.25%
EPS(YoY)

-0.02

-282.00%
Analyst Rating

Hold

May 29, 2024

Hubei Biocause Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

No Data

Hubei Biocause Pharmaceutical Earnings Reports

  • Hubei Biocause Pharmaceutical: 2024 First Quarter Report

    Apr 29 12:00 ET

  • Hubei Biocause Pharmaceutical: 2023 ANNUAL REPORT

    Apr 29 12:00 ET

  • Hubei Biocause Pharmaceutical: 2023 Annual Report Summary

    Apr 29 12:00 ET

  • Tianmao Group: Tianmao Group's performance forecast for the first quarter of 2024

    Apr 15 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 29, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      100.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg